S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Greek authorities rescue 91 migrants from river islet on border with Turkey
WARNING to all American Investors (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Greek authorities rescue 91 migrants from river islet on border with Turkey
WARNING to all American Investors (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Greek authorities rescue 91 migrants from river islet on border with Turkey
WARNING to all American Investors (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Greek authorities rescue 91 migrants from river islet on border with Turkey
WARNING to all American Investors (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
NASDAQ:RXRX

Recursion Pharmaceuticals (RXRX) Short Interest Ratio & Short Volume

$8.23
-0.54 (-6.16%)
(As of 06/2/2023 08:48 PM ET)
Compare
Today's Range
$8.11
$9.33
50-Day Range
$4.56
$9.25
52-Week Range
$4.54
$14.18
Volume
3.09 million shs
Average Volume
1.46 million shs
Market Capitalization
$1.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.40

Recursion Pharmaceuticals Short Interest Data

Current Short Volume
20,000,000 shares
Previous Short Volume
20,440,000 shares
Change Vs. Previous Month
-2.15%
Dollar Volume Sold Short
$112 million
Short Interest Ratio / Days to Cover
12.4
Last Record Date
May 15, 2023
Outstanding Shares
192,360,000 shares
Float Size
115,840,000 shares
Short Percent of Float
17.27%
Today's Trading Volume
3,088,600 shares
Average Trading Volume
1,456,188 shares
Today's Volume Vs. Average
212%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Recursion Pharmaceuticals ?

Sign up to receive the latest short interest report for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RXRX Short Interest Over Time

RXRX Days to Cover Over Time

RXRX Percentage of Float Shorted Over Time


Recursion Pharmaceuticals (NASDAQ:RXRX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202320,000,000 shares $112 million -2.2%17.3%12.4 $5.60
4/30/202320,440,000 shares $97.50 million +2.2%17.8%18.4 $4.77
4/15/202320,000,000 shares $118.80 million +0.9%17.4%19.6 $5.94
3/31/202319,830,000 shares $132.27 million +4.3%17.3%20.3 $6.67
3/15/202319,020,000 shares $142.27 million +8.1%16.6%19 $7.48
2/28/202317,600,000 shares $143.44 million +1.7%15.4%16.4 $8.15
2/15/202317,310,000 shares $146.10 million -3.1%15.2%15.3 $8.44
1/31/202317,870,000 shares $148.86 million +2.2%16.7%14.4 $8.33
1/15/202317,480,000 shares $152.08 million +4.2%15.1%14 $8.70
12/30/202216,780,000 shares $129.37 million +17.8%14.4%13.9 $7.71
12/15/202214,240,000 shares $120.61 million -4.4%12.2%11.9 $8.47
11/30/202214,890,000 shares $139.97 million -0.2%13.5%11.9 $9.40
11/15/202214,920,000 shares $176.95 million -5.6%13.6%12.8 $11.86
10/31/202215,800,000 shares $166.69 million +1.6%19.3%14.1 $10.55
10/15/202215,550,000 shares $163.12 million -3.9%18.4%14.4 $10.49
9/30/202216,180,000 shares $172.16 million +12.4%19.2%14.8 $10.64
9/15/202214,390,000 shares $188.65 million -1.4%17.1%12.2 $13.11
8/31/202214,590,000 shares $153.34 million -7.6%17.4%14.3 $10.51
8/15/202215,790,000 shares $204.64 million -5.8%18.9%15.6 $12.96
7/31/202216,770,000 shares $141.87 million +4.9%20.2%16.6 $8.46
7/15/202215,990,000 shares $135.92 million +11.7%19.3%15.4 $8.50
6/30/202214,310,000 shares $116.48 million +3.0%17.3%13 $8.14
6/15/202213,890,000 shares $92.79 million -0.9%16.7%12.9 $6.68
5/31/202214,020,000 shares $85.80 million +3.4%17.1%12.5 $6.12
5/15/202213,560,000 shares $76.48 million -3.0%16.5%11.3 $5.64
4/30/202213,980,000 shares $86.68 million +0.4%17.1%12.1 $6.20
4/15/202213,920,000 shares $103.84 million -5.6%17.2%11.9 $7.46
3/31/202214,740,000 shares $105.54 million -8.2%16.9%12.7 $7.16
3/15/202216,060,000 shares $100.38 million -1.6%18.7%13.3 $6.25
2/28/202216,320,000 shares $178.70 million +5.0%19.0%11.1 $10.95
2/15/202215,550,000 shares $185.05 million +6.4%17.9%10.4 $11.90
1/31/202214,620,000 shares $173.10 million +5.6%16.7%9.3 $11.84
1/15/202213,840,000 shares $191.13 million +3.3%15.8%8.7 $13.81
12/31/202113,400,000 shares $229.54 million +20.8%15.3%8.5 $17.13
12/15/202111,090,000 shares $219.03 million +4.0%12.6%7.3 $19.75
11/30/202110,660,000 shares $203.82 million -2.8%12.8%9.4 $19.12
11/15/202110,970,000 shares $205.69 million -5.5%13.2%12 $18.75
10/29/202111,610,000 shares $222.33 million -10.8%14.0%15.7 $19.15
10/15/202113,010,000 shares $247.71 million +8.5%15.7%21.3 $19.04
9/30/202111,990,000 shares $275.89 million +31.9%14.5%24.4 $23.01













RXRX Short Interest - Frequently Asked Questions

What is Recursion Pharmaceuticals' current short interest?

Short interest is the volume of Recursion Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 20,000,000 shares of RXRX short. 17.27% of Recursion Pharmaceuticals' shares are currently sold short. Learn More on Recursion Pharmaceuticals' current short interest.

What is a good short interest ratio for Recursion Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RXRX shares currently have a short interest ratio of 12.0. Learn More on Recursion Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Recursion Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Recursion Pharmaceuticals: Susquehanna International Group LLP, Group One Trading L.P., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Recursion Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.27% of Recursion Pharmaceuticals' floating shares are currently sold short.

Is Recursion Pharmaceuticals' short interest increasing or decreasing?

Recursion Pharmaceuticals saw a drop in short interest in May. As of May 15th, there was short interest totaling 20,000,000 shares, a drop of 2.2% from the previous total of 20,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Recursion Pharmaceuticals' float size?

Recursion Pharmaceuticals currently has issued a total of 192,360,000 shares. Some of Recursion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Recursion Pharmaceuticals currently has a public float of 115,840,000 shares.

How does Recursion Pharmaceuticals' short interest compare to its competitors?

17.27% of Recursion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Recursion Pharmaceuticals: SpringWorks Therapeutics, Inc. (25.25%), Kymera Therapeutics, Inc. (21.28%), Vericel Co. (11.96%), BioCryst Pharmaceuticals, Inc. (17.10%), Iovance Biotherapeutics, Inc. (12.86%), Relay Therapeutics, Inc. (25.78%), Arcellx, Inc. (22.12%), Sana Biotechnology, Inc. (33.83%), ImmunityBio, Inc. (23.00%), Replimune Group, Inc. (17.04%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short Recursion Pharmaceuticals stock?

Short selling RXRX is an investing strategy that aims to generate trading profit from Recursion Pharmaceuticals as its price is falling. RXRX shares are trading down $0.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Recursion Pharmaceuticals?

A short squeeze for Recursion Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RXRX, which in turn drives the price of the stock up even further.

How often is Recursion Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXRX, twice per month. The most recent reporting period available is May, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RXRX) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -